These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 30540740)
21. A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast. Zhang XR; He JB; Wang YZ; Du LL G3 (Bethesda); 2018 May; 8(6):2067-2077. PubMed ID: 29703785 [TBL] [Abstract][Full Text] [Related]
22. Generation of site-specific mutant mice using the CRISPR/Cas9 system. Bai M; Li Q; Shao YJ; Huang YH; Li DL; Ma YL Yi Chuan; 2015 Oct; 37(10):1029-35. PubMed ID: 26496755 [TBL] [Abstract][Full Text] [Related]
30. Genome Editing in Mouse Embryos with CRISPR/Cas9. Scott GJ; Gruzdev A Methods Mol Biol; 2019; 1960():23-40. PubMed ID: 30798518 [TBL] [Abstract][Full Text] [Related]
31. Progress in the application of CRISPR: From gene to base editing. Wu W; Yang Y; Lei H Med Res Rev; 2019 Mar; 39(2):665-683. PubMed ID: 30171624 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous precise editing of multiple genes in human cells. Riesenberg S; Chintalapati M; Macak D; Kanis P; Maricic T; Pääbo S Nucleic Acids Res; 2019 Nov; 47(19):e116. PubMed ID: 31392986 [TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-Induced Breaks in Heterochromatin, Visualized by Immunofluorescence. Mitrentsi I; Soutoglou E Methods Mol Biol; 2021; 2153():439-445. PubMed ID: 32840797 [TBL] [Abstract][Full Text] [Related]
35. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628 [TBL] [Abstract][Full Text] [Related]
36. Designed nucleases for targeted genome editing. Lee J; Chung JH; Kim HM; Kim DW; Kim H Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767 [TBL] [Abstract][Full Text] [Related]
37. The influence of eukaryotic chromatin state on CRISPR-Cas9 editing efficiencies. Verkuijl SA; Rots MG Curr Opin Biotechnol; 2019 Feb; 55():68-73. PubMed ID: 30189348 [TBL] [Abstract][Full Text] [Related]
38. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Maruyama T; Dougan SK; Truttmann MC; Bilate AM; Ingram JR; Ploegh HL Nat Biotechnol; 2015 May; 33(5):538-42. PubMed ID: 25798939 [TBL] [Abstract][Full Text] [Related]
39. Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells. Wang Y; Liu KI; Sutrisnoh NB; Srinivasan H; Zhang J; Li J; Zhang F; Lalith CRJ; Xing H; Shanmugam R; Foo JN; Yeo HT; Ooi KH; Bleckwehl T; Par YYR; Lee SM; Ismail NNB; Sanwari NAB; Lee STV; Lew J; Tan MH Genome Biol; 2018 May; 19(1):62. PubMed ID: 29843790 [TBL] [Abstract][Full Text] [Related]
40. The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair. Jasin M; Haber JE DNA Repair (Amst); 2016 Aug; 44():6-16. PubMed ID: 27261202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]